Literature DB >> 3498106

Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation.

P M Plotsky, S Otto, S Sutton.   

Abstract

Secretion of corticotropin releasing factor (CRF) from the hypothalamic paraventricular nuclei into the hypophysial-portal circulation is modulated by a variety of neuronal afferents. Effects of intracerebroventricular acetylcholine (ACH), gamma-aminobutyric acid (GABA) and epinephrine (EPI) on immunoreactive (ir) CRF concentration in portal plasma were directly evaluated in urethanized male rats. ACH (0.1-10 nmole) administration was associated with a dose-dependent elevation of portal irCRF which was attenuated by pretreatment with either muscarinic or nicotinic receptor antagonists. GABA (0.1-10 nmole) also caused inhibition of irCRF concentration in the portal plasma which was prevented by bicuculline pretreatment. Finally, EPI (0.1-10 nmole) facilitated irCRF secretion via alpha 1- and beta-adrenergic mechanisms. These observations provide the first direct information on possible neurotransmitter actions on hypothalamic CRF secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498106     DOI: 10.1016/0024-3205(87)90211-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  24 in total

Review 1.  Neuroactive steroids and anxiety disorders.

Authors:  Jean-Michel Le Mellédo; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2002-05       Impact factor: 6.186

2.  Fetal hypothalamus-pituitary-adrenal responses to estradiol sulfate.

Authors:  Charles E Wood
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

Review 3.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

Review 4.  Molecular basis of pharmacological therapy in Cushing's disease.

Authors:  Diego Ferone; Claudia Pivonello; Giovanni Vitale; Maria Chiara Zatelli; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

Review 5.  Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.

Authors:  S Tsagarakis; A Grossman
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

6.  Effect of CRF injected into the median eminence on GH secretion in female rats under different steroid status.

Authors:  A Puertas; J Frias; E Ruiz; E Ortega
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

7.  Effect of corticotropin releasing factor (CRF) injected into the median eminence on LH secretion in male rats.

Authors:  J Frias; A Puertas; E Ruiz; E Ortega
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

8.  Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus.

Authors:  Rebecca L Cole; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

9.  Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys.

Authors:  Jillian H Broadbear; Gail Winger; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2004-08-21       Impact factor: 4.530

10.  Mechanisms and functional implications of social buffering in infants: Lessons from animal models.

Authors:  Regina M Sullivan; Rosemarie E Perry
Journal:  Soc Neurosci       Date:  2015-09-16       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.